Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 111

Related Citations for PubMed (Select 24767857)

1.

ARID1A/BAF250a as a prognostic marker for gastric carcinoma: a study of 2 cohorts.

Wiegand KC, Sy K, Kalloger SE, Li-Chang H, Woods R, Kumar A, Streutker CJ, Hafezi-Bakhtiari S, Zhou C, Lim HJ, Huntsman DG, Clarke B, Schaeffer DF.

Hum Pathol. 2014 Jun;45(6):1258-68. doi: 10.1016/j.humpath.2014.02.006. Epub 2014 Feb 20.

PMID:
24767857
2.

The clinicopathologic significance of p53 and BAF-250a (ARID1A) expression in clear cell carcinoma of the endometrium.

Fadare O, Gwin K, Desouki MM, Crispens MA, Jones HW 3rd, Khabele D, Liang SX, Zheng W, Mohammed K, Hecht JL, Parkash V.

Mod Pathol. 2013 Aug;26(8):1101-10. doi: 10.1038/modpathol.2013.35. Epub 2013 Mar 22.

3.

ARID1A expression loss in gastric cancer: pathway-dependent roles with and without Epstein-Barr virus infection and microsatellite instability.

Abe H, Maeda D, Hino R, Otake Y, Isogai M, Ushiku AS, Matsusaka K, Kunita A, Ushiku T, Uozaki H, Tateishi Y, Hishima T, Iwasaki Y, Ishikawa S, Fukayama M.

Virchows Arch. 2012 Oct;461(4):367-77. doi: 10.1007/s00428-012-1303-2. Epub 2012 Aug 23.

PMID:
22915242
4.

ARID1A loss correlates with mismatch repair deficiency and intact p53 expression in high-grade endometrial carcinomas.

Allo G, Bernardini MQ, Wu RC, Shih IeM, Kalloger S, Pollett A, Gilks CB, Clarke BA.

Mod Pathol. 2014 Feb;27(2):255-61. doi: 10.1038/modpathol.2013.144. Epub 2013 Jul 26.

5.

Loss of ARID1A/BAF250a-expression in endometriosis: a biomarker for risk of carcinogenic transformation?

Samartzis EP, Samartzis N, Noske A, Fedier A, Caduff R, Dedes KJ, Fink D, Imesch P.

Mod Pathol. 2012 Jun;25(6):885-92. doi: 10.1038/modpathol.2011.217. Epub 2012 Feb 3.

6.

Frequent low expression of chromatin remodeling gene ARID1A in breast cancer and its clinical significance.

Zhang X, Zhang Y, Yang Y, Niu M, Sun S, Ji H, Ma Y, Yao G, Jiang Y, Shan M, Zhang G, Pang D.

Cancer Epidemiol. 2012 Jun;36(3):288-93. doi: 10.1016/j.canep.2011.07.006. Epub 2011 Sep 1.

PMID:
21889920
7.

Loss of ARID1A/BAF250a expression is linked to tumor progression and adverse prognosis in cervical cancer.

Cho H, Kim JS, Chung H, Perry C, Lee H, Kim JH.

Hum Pathol. 2013 Jul;44(7):1365-74. doi: 10.1016/j.humpath.2012.11.007. Epub 2013 Feb 18.

PMID:
23427874
8.

FGFR2, HER2 and cMet in gastric adenocarcinoma: detection, prognostic significance and assessment of downstream pathway activation.

Betts G, Valentine H, Pritchard S, Swindell R, Williams V, Morgan S, Griffiths EA, Welch I, West C, Womack C.

Virchows Arch. 2014 Feb;464(2):145-56. doi: 10.1007/s00428-013-1517-y. Epub 2013 Dec 4.

PMID:
24306956
9.

ARID1A: a potential prognostic factor for breast cancer.

Zhao J, Liu C, Zhao Z.

Tumour Biol. 2014 May;35(5):4813-9. doi: 10.1007/s13277-014-1632-7. Epub 2014 Jan 16.

PMID:
24430365
10.

Overexpression of minichromosome maintenance 2 predicts poor prognosis in patients with gastric cancer.

Yang C, Wen Y, Li H, Zhang D, Zhang N, Shi X, Jiang B, Ma X, Yang P, Tang H, Peng Z, Yang Y.

Oncol Rep. 2012 Jan;27(1):135-42. doi: 10.3892/or.2011.1473. Epub 2011 Sep 22.

PMID:
21947329
11.

Loss of ARID1A expression in colorectal carcinoma is strongly associated with mismatch repair deficiency.

Chou A, Toon CW, Clarkson A, Sioson L, Houang M, Watson N, DeSilva K, Gill AJ.

Hum Pathol. 2014 Aug;45(8):1697-703. doi: 10.1016/j.humpath.2014.04.009. Epub 2014 Apr 24.

PMID:
24925223
12.

Prognostic significance of p53 protein expression in early gastric cancer.

Gonçalves AR, Carneiro AJ, Martins I, de Faria PA, Ferreira MA, de Mello EL, Fogaça HS, Elia CC, de Souza HS.

Pathol Oncol Res. 2011 Jun;17(2):349-55. doi: 10.1007/s12253-010-9333-z. Epub 2010 Nov 30.

PMID:
21116760
13.

Decreased expression of the ARID1A gene is associated with poor prognosis in primary gastric cancer.

Wang DD, Chen YB, Pan K, Wang W, Chen SP, Chen JG, Zhao JJ, Lv L, Pan QZ, Li YQ, Wang QJ, Huang LX, Ke ML, He J, Xia JC.

PLoS One. 2012;7(7):e40364. doi: 10.1371/journal.pone.0040364. Epub 2012 Jul 13.

14.

The clinicopathologic significance of the loss of BAF250a (ARID1A) expression in endometrial carcinoma.

Zhang ZM, Xiao S, Sun GY, Liu YP, Zhang FH, Yang HF, Li J, Qiu HB, Liu Y, Zhang C, Kang S, Shan BE.

Int J Gynecol Cancer. 2014 Mar;24(3):534-40. doi: 10.1097/IGC.0000000000000092.

PMID:
24557437
15.

DNA damage response-related proteins in gastric cancer: ATM, Chk2 and p53 expression and their prognostic value.

Lee HE, Han N, Kim MA, Lee HS, Yang HK, Lee BL, Kim WH.

Pathobiology. 2014;81(1):25-35. doi: 10.1159/000351072. Epub 2013 Aug 21.

16.

Overexpressed transcription factor FOXM1 is a potential diagnostic and adverse prognostic factor in postoperational gastric cancer patients.

Li X, Qi W, Yao R, Tang D, Liang J.

Clin Transl Oncol. 2014 Mar;16(3):307-14. doi: 10.1007/s12094-013-1076-3. Epub 2013 Jul 20.

PMID:
23873251
17.

Loss of ARID1A expression and its relationship with PI3K-Akt pathway alterations, TP53 and microsatellite instability in endometrial cancer.

Bosse T, ter Haar NT, Seeber LM, v Diest PJ, Hes FJ, Vasen HF, Nout RA, Creutzberg CL, Morreau H, Smit VT.

Mod Pathol. 2013 Nov;26(11):1525-35. doi: 10.1038/modpathol.2013.96. Epub 2013 May 24.

18.
19.

Increased MMP-21 expression is associated with poor overall survival of patients with gastric cancer.

Wu T, Li Y, Lu J, Qiao Q, Bao G, Wang N, He X, Du X.

Med Oncol. 2013 Mar;30(1):323. doi: 10.1007/s12032-012-0323-8. Epub 2012 Dec 30.

PMID:
23275114
20.

The chromatin remodeling gene ARID1A is a new prognostic marker in clear cell renal cell carcinoma.

Lichner Z, Scorilas A, White NM, Girgis AH, Rotstein L, Wiegand KC, Latif A, Chow C, Huntsman D, Yousef GM.

Am J Pathol. 2013 Apr;182(4):1163-70. doi: 10.1016/j.ajpath.2013.01.007. Epub 2013 Feb 12.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk